These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 20634637

  • 1. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G, Allasino B, Bovio S, Saba L, Ardito A, Angeli A, Terzolo M.
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [Abstract] [Full Text] [Related]

  • 2. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [Abstract] [Full Text] [Related]

  • 3. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
    Khawandanah D, ElAsmar N, Arafah BM.
    Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
    [Abstract] [Full Text] [Related]

  • 4. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M, Osella G, Alì A, Borretta G, Cesario F, Paccotti P, Angeli A.
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
    [Abstract] [Full Text] [Related]

  • 5. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [Abstract] [Full Text] [Related]

  • 6. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
    Vieira-Correa M, Giorgi RB, Oliveira KC, Hayashi LF, Costa-Barbosa FA, Kater CE.
    J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.
    Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, Giampalma E, Mosconi C, Golfieri R, Paccapelo A, Pagotto U, Pasquali R.
    Lancet Diabetes Endocrinol; 2014 May; 2(5):396-405. PubMed ID: 24795253
    [Abstract] [Full Text] [Related]

  • 8. Subclinical Cushing's syndrome: current concepts and trends.
    Zografos GN, Perysinakis I, Vassilatou E.
    Hormones (Athens); 2014 May; 13(3):323-37. PubMed ID: 25079456
    [Abstract] [Full Text] [Related]

  • 9. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F, Antonelli G, Frigo AC, Regazzo D, Plebani M, Boscaro M, Scaroni C.
    J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
    [Abstract] [Full Text] [Related]

  • 10. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ, Liu YP, Yu YR.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [Abstract] [Full Text] [Related]

  • 11. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P, Bertolini M, Losa M, Cavagnini F.
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
    Ueland GÅ, Methlie P, Kellmann R, Bjørgaas M, Åsvold BO, Thorstensen K, Kelp O, Thordarson HB, Mellgren G, Løvås K, Husebye ES.
    Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
    [Abstract] [Full Text] [Related]

  • 13. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [Abstract] [Full Text] [Related]

  • 14. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.
    Ceccato F, Barbot M, Albiger N, Antonelli G, Zilio M, Todeschini M, Regazzo D, Plebani M, Lacognata C, Iacobone M, Mantero F, Boscaro M, Scaroni C.
    Endocrine; 2018 Mar; 59(3):510-519. PubMed ID: 28956262
    [Abstract] [Full Text] [Related]

  • 15. Low DHEAS: A Sensitive and Specific Test for the Detection of Subclinical Hypercortisolism in Adrenal Incidentalomas.
    Dennedy MC, Annamalai AK, Prankerd-Smith O, Freeman N, Vengopal K, Graggaber J, Koulouri O, Powlson AS, Shaw A, Halsall DJ, Gurnell M.
    J Clin Endocrinol Metab; 2017 Mar 01; 102(3):786-792. PubMed ID: 27797672
    [Abstract] [Full Text] [Related]

  • 16. Contralateral adrenal suppression on adrenocortical scintigraphy provides good evidence showing subclinical cortisol overproduction from unilateral adenomas.
    Katabami T, Ishii S, Obi R, Asai S, Tanaka Y.
    Endocr J; 2016 Dec 30; 63(12):1123-1132. PubMed ID: 27616151
    [Abstract] [Full Text] [Related]

  • 17. Accuracy of several parameters of hypothalamic-pituitary-adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma.
    Eller-Vainicher C, Morelli V, Salcuni AS, Battista C, Torlontano M, Coletti F, Iorio L, Cairoli E, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A, Chiodini I.
    Eur J Endocrinol; 2010 Dec 30; 163(6):925-35. PubMed ID: 20881060
    [Abstract] [Full Text] [Related]

  • 18. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W.
    J Clin Endocrinol Metab; 1992 Sep 30; 75(3):826-32. PubMed ID: 1517373
    [Abstract] [Full Text] [Related]

  • 19. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
    Valli N, Catargi B, Ronci N, Vergnot V, Leccia F, Ferriere JM, Chene G, Grenier N, Laurent F, Tabarin A.
    Eur J Endocrinol; 2001 Apr 30; 144(4):401-8. PubMed ID: 11275951
    [Abstract] [Full Text] [Related]

  • 20. ACTH following overnight dexamethasone suppression can be used in the verification of autonomous cortisol secretion in patients with adrenal incidentalomas.
    Puvaneswaralingam S, Kjellbom A, Lindgren O, Löndahl M, Olsen H.
    Clin Endocrinol (Oxf); 2021 Feb 30; 94(2):168-175. PubMed ID: 33108675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.